Labcorp EVP granted 1,584 performance shares
LABCORP HOLDINGS INC. executive EVP, Diagnostics Bryan T. Vaughn received 1,584 shares of common stock on March 26, 2026 as a performance award tied to results over the three-year period ended December 31, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
LABCORP HOLDINGS INC. executive EVP, Diagnostics Bryan T. Vaughn received 1,584 shares of common stock on March 26, 2026 as a performance award tied to results over the three-year period ended December 31, 2025. To cover tax obligations, 451 shares were withheld at $268.38 per share, leaving him with 6,745.5702 directly owned shares after these transactions.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,584 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 451 | $268.38 | $121K |
Footnotes (2)
- F1. Shares acquired on March 26, 2026, pursuant to a performance award granted on February 7, 2023, relating to performance during the three-year period ended December 31, 2025.
- F2. Stock withholding to satisfy tax withholding obligations.
Key Figures
Key Terms
performance award financial
stock withholding financial
tax withholding obligations financial
Grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did LH executive Bryan T. Vaughn report?
Was the LABCORP (LH) insider transaction a market purchase or sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.